ArticleFrontiers in pharmacology2022

Inhibition of the PINK1-Parkin Pathway Enhances the Lethality of Sorafenib and Regorafenib in Hepatocellular Carcinoma.

Shun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.